Greenwich LifeSciences, Inc.

The momentum for this stock is not very good. Greenwich LifeSciences, Inc. is not a good growth stock. Tradey thinks it is not wise to invest in Greenwich LifeSciences, Inc..

News

Greenwich LifeSciences, Inc. (NASDAQ:GLSI) Sees Large Growth in Short Interest

Zolmax Greenwich LifeSciences, Inc. (NASDAQ:GLSI - Get Free Report) saw a significant growth in short interest in the month of August. As of August 15th, there was short interest totalling 451,700 shares...\n more…

Head-To-Head Comparison: Avacta Group (OTCMKTS:AVCTF) and Greenwich LifeSciences (NASDAQ:GLSI)

Zolmax Greenwich LifeSciences (NASDAQ:GLSI - Get Free Report) and Avacta Group (OTCMKTS:AVCTF - Get Free Report) are both medical companies, but which is the superior business? We will contrast the two...\n more…

HC Wainwright Raises Greenwich LifeSciences (NASDAQ:GLSI) Price Target to $38.00

Zolmax Greenwich LifeSciences (NASDAQ:GLSI - Free Report) had its price objective upped by HC Wainwright from $36.00 to $38.00 in a research report released on Friday morning, Benzinga reports. HC...\n more…

HC Wainwright Increases Greenwich LifeSciences (NASDAQ:GLSI) Price Target to $38.00

Zolmax Greenwich LifeSciences (NASDAQ:GLSI - Get Free Report) had its target price hoisted by research analysts at HC Wainwright from $36.00 to $38.00 in a research report issued to clients and investors...\n more…

Greenwich LifeSciences (NASDAQ:GLSI) Price Target Raised to $38.00 at HC Wainwright

Ticker Report Greenwich LifeSciences (NASDAQ:GLSI - Free Report) had its price objective lifted by HC Wainwright from $36.00 to $38.00 in a research report sent to investors on Friday morning, Benzinga reports. HC...\n more…

Greenwich LifeSciences price target raised by $2 at H.C. Wainwright, here's why

The Fly See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...\n more…